Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yulene Kock"'
Autor:
Erika Mohr-Holland, Anja Reuter, Jennifer Furin, Anthony Garcia-Prats, Virginia De Azevedo, Vanessa Mudaly, Yulene Kock, Laura Trivino-Duran, Petros Isaakidis, Jennifer Hughes
Publikováno v:
EClinicalMedicine, Vol 20, Iss , Pp - (2020)
Background: Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10–19 years) with injectable-free regimens containing these drugs in K
Externí odkaz:
https://doaj.org/article/469c98a39c1048e9b291e9296219bf98
Autor:
Anja Reuter, Buci Beko, Boniwe Memani, Jennifer Furin, Johnny Daniels, Erickmar Rodriguez, Hermann Reuter, Lize Weich, Petros Isaakidis, Erin von der Heyden, Yulene Kock, Erika Mohr-Holland
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 7, Iss 2, p 21 (2022)
Substance use (SU) is associated with poor rifampicin-resistant tuberculosis (RR-TB) treatment outcomes. In 2017, a SBIRT (SU screening-brief intervention-referral to treatment) was integrated into routine RR-TB care in Khayelitsha, South Africa. Thi
Externí odkaz:
https://doaj.org/article/07052e021643445cbfb2fc1e87096963
Autor:
Erika Mohr, Leigh Snyman, Zodwa Mbakaz, Judy Caldwell, Virginia DeAzevedo, Yulene Kock, Laura Trivino Duran, Emilie Venables
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203888 (2018)
BACKGROUND:Self-administered treatment (SAT), a differentiated model of care for rifampicin-resistant tuberculosis (RR-TB), might address adherence challenges faced by patients and health care systems. This study explored patient, health-care worker
Externí odkaz:
https://doaj.org/article/063458eb7c3f4c318afd465474ad9761
Autor:
Harry Moultrie, Ebrahim Variava, Zaheda Bhyat., Martin Enwerem, Simon Schaaf, Xavier Padanilam, Norbert Ndjeka, Nana Okozi, Minty van der Meulen, Lavania Joseph, Yulene Kock, Shaheed V. Omar, Nazir Ahmed Ismail, Hannetjie Ferreira, Francesca Conradie, Vancy Letsaolo, Anja Reuter, Gary Maartens, Farzana Ismail, Jennifer Hughes, Julian Te Riele, Rodolf Romero, Graeme Meintjes, Dumisani Ngcamu
Publikováno v:
The Lancet Infectious Diseases. 22:496-506
Summary Background Bedaquiline improves outcomes of patients with rifampicin-resistant and multidrug-resistant (MDR) tuberculosis; however, emerging resistance threatens this success. We did a cross-sectional and longitudinal analysis evaluating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da4ddde1345bae8016a82b65e5a1081
https://doi.org/10.1016/s1473-3099(21)00470-9
https://doi.org/10.1016/s1473-3099(21)00470-9
Autor:
Martin Enwerem, Francesca Conradie, Gary Maartens, Nazir Ahmed Ismail, Hannetjie Ferreira, Jennifer Hughes, Graeme Meintjes, Anja Reuter, R. Romero, Iqbal Master, Xavier Padanilam, Yulene Kock, Norbert Ndjeka, H S Schaaf, J te Riele
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 24(10)
Worldwide uptake of new drugs in the treatment of rifampicin-resistant tuberculosis (RR-TB) has been extremely low. In June 2018, ahead of the release of the updated WHO guidelines for the management of RR-TB, South Africa announced that bedaquiline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a360e3d84ed43c4d5ddd35c07411b0
https://pubmed.ncbi.nlm.nih.gov/33126942
https://pubmed.ncbi.nlm.nih.gov/33126942
Autor:
Kathryn Manning, Tamaryn Fox, Vanessa Mudaly, Yulene Kock, Ying Zhao, Andrew Boulle, Joshua Leslie, Ntokozo Khomo, Nicki Tiffin, Sean Wasserman, Annemie Stewart, Graeme Meintjes
Publikováno v:
Clinical Infectious Diseases. 68:1522-1529
Background Bedaquiline is used as a substitute for second-line injectable (SLI) intolerance in the treatment of multidrug-resistant (MDR) tuberculosis, but the efficacy and safety of this strategy is unknown. Methods In this retrospective cohort stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a0d630b26d43cc99ff5d57e36a9765
https://doi.org/10.1093/cid/ciy727
https://doi.org/10.1093/cid/ciy727
Autor:
Anthony J. Garcia-Prats, Jennifer Hughes, Virginia De Azevedo, Erika Mohr-Holland, Yulene Kock, Laura Trivino-Duran, Vanessa Mudaly, Jennifer Furin, Anja Reuter, Petros Isaakidis
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 20, Iss, Pp-(2020)
EClinicalMedicine, Vol 20, Iss, Pp-(2020)
Background: Limited data exist on use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10-19 years) with injectable-free regimens containing these drugs in Khayeli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093b84ac709b051300f09928375f8e2c
https://doi.org/10.2139/ssrn.3436257
https://doi.org/10.2139/ssrn.3436257
Autor:
Anja Reuter, R. Romero, Yulene Kock, J te Riele, Ebrahim Variava, Hannetjie Ferreira, H S Schaaf, Martin Enwerem, Xavier Padanilam, Graeme Meintjes, Francesca Conradie, Gary Maartens, Farzana Ismail, Jennifer Hughes, Norbert Ndjeka, Nazir Ahmed Ismail
Publikováno v:
South African Medical Journal. 111:285
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c295ab9af78b860eefd47bc317615a2c
https://doi.org/10.7196/samj.2021.v111i4.15568
https://doi.org/10.7196/samj.2021.v111i4.15568
Autor:
Virginia De Avezedo, Johnny Daniels, Jennifer Hughes, Helen Cox, Petros Isaakidis, Anja Reuter, Laura Trivino Duran, Yulene Kock, Goodman Makhanda, Gabriella Ferlazzo, Jennifer Furin, Busisiwe Beko, Erika Mohr-Holland
Publikováno v:
The European Respiratory Journal
Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa. This was a retrospective cohort study of patients receiving Dlm-containin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c1021330b1d856c97ea5b29d94d1fa
https://doi.org/10.1183/13993003.00837-2020
https://doi.org/10.1183/13993003.00837-2020
Autor:
Johnny Daniels, Jeffrey K. Edwards, Helen Cox, Petros Isaakidis, Sarah Jane Steele, Laura Trivino Duran, Serge Ade, Erika Mohr, Gabriella Ferlazzo, Virginia De Azevedo, Amir Shroufi, Guido Benedetti, Anja Reuter, Natavan Alikhanova, Yulene Kock, Jennifer Furin, Jennifer Hughes
Publikováno v:
European Respiratory Journal. 51:1800017
Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa.This was a retrospective cohort study of patients receiving Dlm-containing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ef4d9105eef86c7430e7d0a1cc61f0
https://doi.org/10.1183/13993003.00017-2018
https://doi.org/10.1183/13993003.00017-2018